• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1600049 托格列净 tofogliflozin Active ingredient Chemical Drugs(3.1) New Drug Application 2016-06-02 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2017-05-22 view
CXHL1600050 托格列净片 tofogliflozin Tablet Chemical Drugs(3.1) New Drug Application 2016-06-02 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2017-05-11 view
JXHL1900103 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme BV In Review 2019-05-11 view
JXHL1900102 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme BV In Review 2019-05-11 view
JXHL1900101 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme Corp In Review 2019-05-11 view
JXHL1900100 艾托格列净二甲双胍片 ertugliflozin;metformin hydrochloride Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-13 Merck Sharp & Dohme Corp In Review 2019-05-11 view
JYHB2200192 艾托格列净片 ertugliflozin Tablet Chemical Drugs Supplementary Application 2022-04-11 view
JYHB2101055 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2021-04-23 view
JYHZ2400270 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) License Renew 2024-10-11 view
JYHB2002203 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2020-11-02 默沙东研发(中国)有限公司 MSD R&D (China) Co Ltd Filed 2020-11-20 view
JYHB2400450 艾托格列净片 ertugliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2024-08-15 view